Commodore Capital LP - 31 Dec 2024 SCHEDULE 13G/A Report for Bright Minds Biosciences Inc. Common Shares, without par value (DRUG)

Filing Manager
Commodore Capital LP
Reporting Manager
COMMODORE CAPITAL LP
Security
Bright Minds Biosciences Inc. Common Shares, without par value
Symbol
DRUG
Shares outstanding
6,944,444 shares
Disclosed Ownership
500,000 shares
Ownership
7.2%
Form type
SCHEDULE 13G/A
Filing time
14 Feb 2025, 16:05:23 UTC
Date of event
31 Dec 2024
Next filing
17 Feb 2026
SEC
View on sec.gov

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
COMMODORE CAPITAL LP 7.2% 500,000 0 500,000 /s/ Michael Kramarz Michael Kramarz, Managing Partner
Commodore Capital Master LP 7.2% 500,000 0 500,000 /s/ Michael Kramarz Michael Kramarz, Authorized Signatory